- Familiar format at a special price / Get The Indian Express e-paper at a limited-period annual price of Rs 999
- Maharashtra minister Parab in ED net, Sena says vendetta
- Will work as city’s local guardian: Newly appointed Delhi L-G Vinai Kumar Saxena
- First Budget of Yogi 2.0 puts focus on election promises
- NDA rule period of misery, says Cong; BJP calls it ‘torn old party’
- Yes Bank-DHFL case: realtor Avinash Bhosale arrested by CBI
AstraZeneca
ASTRAZENECA NEWS
‘Vaccines give extra protection to those with immunity from previous Covid infection’
April 01, 2022 11:44 am
Participants were selected from national disease surveillance and vaccination databases if they had a PCR confirmed SARS-CoV-2 reinfection, at least 90 days after they contracted the initial infection (22,566 people in total).
‘Covishield effective against Omicron after two shots of same or other vaccines’
January 13, 2022 7:29 pm
🔴 The vaccine, sold as Covishield in India and Vaxzevria elsewhere, also enhanced the body’s immune response to the virus’s Alpha, Beta, Delta and Gamma variants also, AstraZeneca added.
Explained: What scientists have found about a class of antibodies that can neutralise the Omicron variant
December 30, 2021 7:58 pm
The antibodies identified by the scientists target areas of the virus spike protein that remain unchanged as it mutates.
Booster dose with AstraZeneca vaccine found to work against Omicron
December 24, 2021 11:27 am
The AstraZeneca vaccine, being marketed under the brand names Covishield, manufactured in India, and Vaxzevria, produced in South Korea, was developed at the laboratories of the University of Oxford. The current study was conducted by a different team of researchers at the same university.
AstraZeneca, Novavax say their shots protect from Omicron
December 23, 2021 6:02 pm
🔴 Coronavirus infections have soared across much of the world as the highly infectious Omicron variant has spread, triggering new curbs in many countries.
AstraZeneca’s antibody combination retains neutralising activity against Omicron: Study
December 18, 2021 8:49 am
About 2 per cent of the global population is considered at increased risk of an inadequate response to a Covid-19 vaccine.
Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: UK study
December 07, 2021 9:49 am
If the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca-Oxford, according to researchers at the University of Oxford.
AstraZeneca booster OK, says paper; Serum Institute seeks nod
December 03, 2021 1:26 am
🔴 Lancet's COV-BOOST study, based on a UK trial, looked at the safety, immune response and side-effects of seven vaccines when used as a third booster jab after 10-11 weeks.
Possible new links between AstraZeneca vaccine and blood clots found
December 02, 2021 10:02 pm
The clots have been more common after a first dose than second, with 426 cases reported to the UK regulator as of Nov. 17 from more than 24 million first and second shots given.
AstraZeneca antibody combo: twin trails indicate single dose helps prevent, treat Covid
November 23, 2021 1:43 pm
AstraZeneca, based in the UK, had licensed coronavirus-neutralising antibodies from Vanderbilt University, US, in June 2020, and had advanced a pair of these monoclonal antibodies mAbs into clinical development.
Best of Express
CitiesVIPs get the treatment: IAS officers who got athletes out are moved to Ladakh, Arunachal 
SportsRelief on track, Thyagraj stadium gates open as Delhi govt extends time until 10 pm
EntertainmentGoodfellas actor Ray Liotta passes away
EntertainmentKamal Haasan on north vs south cinema debate: ‘For me, Taj Mahal is mine and Madurai temple is yours’
TrendingWatch: Students help differently-abled classmate to evacuate during earthquake
TrendingNetizens pay tribute to teachers who lost their lives in Texas school shooting
SportsHard life of the ever-smiling cricketer Rinku Singh, KKR's rising star
SportsHow captain Hardik Pandya fuelled Gujarat Titans’s ride to top?
OpinionMaking sense of the GST bonanza
Why do many in the US resist stricter gun laws?
Geetanjali Shree’s 'Tomb of Sand' becomes 1st Hindi novel to win International Booker Prize
Welcome to the elusive world of crypto mining
May 27: Latest News
First Budget of Yogi 2.0 puts focus on election promises
PM in Chennai: Stalin demands official status for Tamil, even as Modi calls the language ‘eternal’
Rajasthan minister slams Chief Minister Ashok Gehlot’s Principal Secretary- How captain Hardik Pandya fuelled Gujarat Titans’ ride to top
Four on motorcycle target private firm’s country head, snatch chain on Gurgaon’s Golf Course Road
Trump must testify in New York probe, appeals court rules
In a former mafia stronghold, art remembers, and warns
Arvind Kejriwal to Bhupendra Patel: Two rallies, two messages from Gujarat tribal leader Vasava
‘Adequate security measures to be in place for free and fair bypolls in Tripura’: Chief electoral officer
Yasin Malik: Kashmir militancy’s long arc, shadow of Pakistan